Discussion Forum

Drug-eluting stents (DES) have revolutionized the treatment of obstructive coronary disease and expanding their applications to the periphery is inevitable. However, a better understanding of stent-associated restenosis in the periphery is needed.… | Read More

As new technologies and procedures are introduced, the question of what’s best for the patient is extremely important. Physicians must be clear about why they want to offer alternatives to the standard of care. Is there really no other option for… | Read More

In our experience, the “when” occurred in the late 1990’s for the CLI subset of SFA/popliteal disease (in our experience, 40-50% of CLI patients will have SFA/popliteal involved and 30-40% in LACI trial) and the “when” began a year or so ago for… | Read More